AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Cardio Diagnostics Holdings Inc. Common stock
XNAS · usd
SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
FIGI BBG013P0VV74
1.69▼ 0.02 (-0.88%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
1.71
Day's Range
1.69 – 1.80
52-Week Range
0.97 – 7.91
Volume
9,199
Avg Volume
30.5K
Share Statistics
Shares Outstanding
Employees
17
Exchange
XNAS
Listed
2022-10-26
Share count as of August 7, 2026

Cardio Diagnostics Holdings Inc. Common stock (CDIO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Cardio Diagnostics Holdings Inc. Common stock (CDIO)
What is Cardio Diagnostics Holdings Inc. Common stock's Market Cap?
Cardio Diagnostics Holdings Inc. Common stock's Market Cap is $5.0M, based on as-reported figures from SEC (XBRL) filings.
What is Cardio Diagnostics Holdings Inc. Common stock's Price / Sales?
Cardio Diagnostics Holdings Inc. Common stock's Price / Sales is 346.1×, based on as-reported figures from SEC (XBRL) filings.
What is Cardio Diagnostics Holdings Inc. Common stock's Revenue (TTM)?
Cardio Diagnostics Holdings Inc. Common stock's Revenue (TTM) is $14.4K, based on as-reported figures from SEC (XBRL) filings.
What is Cardio Diagnostics Holdings Inc. Common stock's Net Income (TTM)?
Cardio Diagnostics Holdings Inc. Common stock's Net Income (TTM) is -$6.5M, based on as-reported figures from SEC (XBRL) filings.
What is Cardio Diagnostics Holdings Inc. Common stock's EBITDA?
Cardio Diagnostics Holdings Inc. Common stock's EBITDA is -$6.4M, based on as-reported figures from SEC (XBRL) filings.
What is Cardio Diagnostics Holdings Inc. Common stock's Diluted EPS (TTM)?
Cardio Diagnostics Holdings Inc. Common stock's Diluted EPS (TTM) is -2.19, based on as-reported figures from SEC (XBRL) filings.
What is Cardio Diagnostics Holdings Inc. Common stock's EBITDA Margin?
Cardio Diagnostics Holdings Inc. Common stock's EBITDA Margin is -44535.4%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CDIOAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+470.2%-21.2%-56.6%
Operating expenses
Selling, General and Administrative Expense
Research and development expense——
Depreciation Expense——
Total operating expenses
% of revenue28050.5%41259.5%60050.9%
Loss from operations
% of revenue-27950.5%-41159.5%-59950.9%
Other income (expenses)
Total Interest Income
Interest expense
Total other (expenses)
Income Before Tax
Income Tax Expense———
Net loss
% of revenue-28012.5%-41219.9%-60053.8%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)